Literature DB >> 19487222

Gastrointestinal complications: the most frequent internal complications of systemic sclerosis.

A Forbes1, I Marie.   

Abstract

Manifestations of SSc in the gastrointestinal (GI) tract are common, occurring in 50-90% of patients. They typically result from the fibrosis that characterizes this disease. Manifestations of SSc can affect many sites within the GI tract, and patients may experience substantial dysfunction in the processes of motility, digestion, absorption and excretion. Oesophageal dysfunction is the most common GI manifestation, but patients may also experience dysfunction of the stomach, small intestine, colon and rectum, each of which can be responsible for severe and distressing symptoms. At present, few specific therapeutic options are available for the treatment of these patients, but relief of symptoms is often possible with appropriate knowledge and support. It is therefore particularly important to identify, monitor and manage these patients carefully, with a view to minimizing further degeneration and maximizing quality of life.

Entities:  

Mesh:

Year:  2009        PMID: 19487222     DOI: 10.1093/rheumatology/ken485

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  32 in total

1.  Severe gastrointestinal disease in very early systemic sclerosis is associated with early mortality.

Authors:  Nicolas Richard; Marie Hudson; Mianbo Wang; Geneviève Gyger; Susanna Proudman; Wendy Stevens; Mandana Nikpour; Murray Baron
Journal:  Rheumatology (Oxford)       Date:  2019-04-01       Impact factor: 7.580

2.  Management of gastrointestinal involvement in scleroderma.

Authors:  Vivek Nagaraja; Zsuzsanna H McMahan; Terri Getzug; Dinesh Khanna
Journal:  Curr Treatm Opt Rheumatol       Date:  2015-03-01

3.  "Beet" the cold: beetroot juice supplementation improves peripheral blood flow, endothelial function, and anti-inflammatory status in individuals with Raynaud's phenomenon.

Authors:  Anthony I Shepherd; Joseph T Costello; Stephen J Bailey; Nicolette Bishop; Alex J Wadley; Steven Young-Min; Mark Gilchrist; Harry Mayes; Danny White; Paul Gorczynski; Zoe L Saynor; Heather Massey; Clare M Eglin
Journal:  J Appl Physiol (1985)       Date:  2019-07-25

Review 4.  The role of high-resolution manometry in the assessment of upper gastrointestinal involvement in systemic sclerosis: a systematic review.

Authors:  Wouter Schutyser; Ludovic Cruyt; Jean-Baptiste Vulsteke; Jan L Lenaerts; Ellen De Langhe
Journal:  Clin Rheumatol       Date:  2019-11-11       Impact factor: 2.980

5.  Current and Future Outlook on Disease Modification and Defining Low Disease Activity in Systemic Sclerosis.

Authors:  Vivek Nagaraja; Marco Matucci-Cerinic; Daniel E Furst; Masataka Kuwana; Yannick Allanore; Christopher P Denton; Ganesh Raghu; Vallerie Mclaughlin; Panduranga S Rao; James R Seibold; John D Pauling; Michael L Whitfield; Dinesh Khanna
Journal:  Arthritis Rheumatol       Date:  2020-05-18       Impact factor: 10.995

6.  Low prevalence of coeliac disease in patients with systemic sclerosis: a cross-sectional study of a registry cohort.

Authors:  Lindsy J Forbess; Jessica K Gordon; Kamini Doobay; Brian P Bosworth; Stephen Lyman; Morgana L Davids; Robert F Spiera
Journal:  Rheumatology (Oxford)       Date:  2013-01-18       Impact factor: 7.580

7.  High inter-individual variability of vardenafil pharmacokinetics in patients with pulmonary hypertension.

Authors:  A M Sandqvist; D Henrohn; J Schneede; M Hedeland; H C Egeröd; U G Bondesson; B G Wikström
Journal:  Eur J Clin Pharmacol       Date:  2012-06-26       Impact factor: 2.953

8.  Evaluation of risk factors for pseudo-obstruction in systemic sclerosis.

Authors:  Eric Dein; Pei-Lun Kuo; Yun Soo Hong; Laura K Hummers; Christopher A Mecoli; Zsuzsanna H McMahan
Journal:  Semin Arthritis Rheum       Date:  2019-05-23       Impact factor: 5.532

Review 9.  Measuring response in the gastrointestinal tract in systemic sclerosis.

Authors:  Dinesh Khanna; Vivek Nagaraja; Heather Gladue; William Chey; Mark Pimentel; Tracy Frech
Journal:  Curr Opin Rheumatol       Date:  2013-11       Impact factor: 5.006

10.  Effectiveness of Saccharomyces boulardii and Metronidazole for Small Intestinal Bacterial Overgrowth in Systemic Sclerosis.

Authors:  Grettel García-Collinot; Eduardo Osiris Madrigal-Santillán; Michel A Martínez-Bencomo; Rosa A Carranza-Muleiro; Luis J Jara; Olga Vera-Lastra; Daniel H Montes-Cortes; Gabriela Medina; María Pilar Cruz-Domínguez
Journal:  Dig Dis Sci       Date:  2019-09-23       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.